GM Results and Total Voting Rights and Exercise of Warrants Issued4 Nov 2020 11:29
Some great news ahead of the AGM tomorrow.
The Company's General Meeting ("GM") was held today at 10.30am. All resolutions were passed
Acquisition of Pharm2Farm
Shareholders have now approved the Company's acquisition of Pharm2Farm Limited ("P2F"), and accordingly, the acquisition will be completed on 5 November 2020.
On completion of the Acquisition, Braveheart will hold 509,992,405 ordinary shares in the Company, representing 34.08 per cent. of the enlarged issued share capital of the Company. Dr. Gareth Cave will hold 289,645,185 ordinary shares in the Company, representing 19.35 per cent. of the enlarged issued share capital of the Company.
Exercise of warrants
The Company has received notification to exercise a further 6,000,000 warrants at an exercise price of 0.5p each. The consideration received by the Company will be £30,000.
The 6,000,000 new Ordinary Shares ("Shares") arising from the exercise of these warrants have now been issued, and application has been made for them to be admitted to trading on AIM ("Admission"). It is expected that Admission will become effective and dealings will commence at 8:00a.m. on or around 11 November 2020.
Following Admission, the Company will have 1,502,627,261 ordinary shares of 0.01p each in issue, none of which are held in treasury. Therefore, the total number of voting rights in the Company is 1,502,627,261.